
CompanionCBD
OperatingCompanionCBD, Inc.
Retail & Consumer · Scottsdale, AZ · Founded 2018
Manufacturing CBD-based soft chews for the companion animal health market...
Financials
FY2017–FY2018 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inBlue bars are the pre-money valuation the company stated for a priced round.
Fundraising history
Team
3 people
A serial entrepreneur with 24 years of global sales, branding, marketing, distribution and consulting experience. Brad has worked in a number of different industries, ranging from: medical device, real estate development, biotech/pharmaceutical, environmental and entertainment distribution.

A practicing veterinarian for over 19 years, and advocate for the clinical use of CBD in clinical practice, Dr. Josh Sosnow is a nationally-recognized CBD educator in the veterinary community. His Principal Occupation is President at Sosnow Animal Hospitals, P.C and works with CompanionCBD 50+ hours a week.
Michael has over 30 years of experience as a software developer both founding and running technical startups in the development and IT spaces. He has been a technical and management leader in the veterinary industry for 15 years.
Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 0 of 7 annual reports (FY2019–FY2025)
Missing: 2019, 2020, 2021, 2022, 2023, 2024, 2025
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.